NO2252275T3 - - Google Patents

Info

Publication number
NO2252275T3
NO2252275T3 NO09709833A NO09709833A NO2252275T3 NO 2252275 T3 NO2252275 T3 NO 2252275T3 NO 09709833 A NO09709833 A NO 09709833A NO 09709833 A NO09709833 A NO 09709833A NO 2252275 T3 NO2252275 T3 NO 2252275T3
Authority
NO
Norway
Application number
NO09709833A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2252275T3 publication Critical patent/NO2252275T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO09709833A 2008-02-13 2009-02-13 NO2252275T3 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2821808P 2008-02-13 2008-02-13
PCT/US2009/034162 WO2009103035A2 (en) 2008-02-13 2009-02-13 Templated open flocs of anisotropic particles for enhanced pulmonary delivery

Publications (1)

Publication Number Publication Date
NO2252275T3 true NO2252275T3 (ko) 2018-04-28

Family

ID=40955349

Family Applications (1)

Application Number Title Priority Date Filing Date
NO09709833A NO2252275T3 (ko) 2008-02-13 2009-02-13

Country Status (7)

Country Link
US (6) US20090208582A1 (ko)
EP (1) EP2252275B1 (ko)
AU (1) AU2009214443B2 (ko)
CA (1) CA2723314C (ko)
DK (1) DK2252275T3 (ko)
NO (1) NO2252275T3 (ko)
WO (1) WO2009103035A2 (ko)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009214443B2 (en) 2008-02-13 2013-10-10 Board Of Regents, The University Of Texas System Templated open flocs of anisotropic particles for enhanced pulmonary delivery
KR101639098B1 (ko) 2009-03-26 2016-07-12 풀매트릭스 오퍼레이팅 컴퍼니, 인크 폐 질환 치료용 건조 분말 제형 및 방법
US8506799B2 (en) * 2009-09-09 2013-08-13 ClearCorp Suspended particle characterization system for a water processing facility
US9248110B2 (en) 2010-03-18 2016-02-02 Steven Lehrer Compositions and methods of treating and preventing lung cancer and lymphangioleiomyomatosis
US20110229418A1 (en) * 2010-03-18 2011-09-22 Steven Lehrer Compositions and Methods of Treating and Preventing Lung Cancer
US9228785B2 (en) 2010-05-04 2016-01-05 Alexander Poltorak Fractal heat transfer device
EP2448571B1 (en) 2010-08-30 2013-06-12 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
US9061352B2 (en) 2010-08-30 2015-06-23 Pulmatrix, Inc. Dry powder formulations and methods for treating pulmonary diseases
WO2012050945A1 (en) 2010-09-29 2012-04-19 Pulmatrix, Inc. Cationic dry powders
EP4008326A1 (en) 2010-09-29 2022-06-08 Pulmatrix Operating Company, Inc. Monovalent metal cation dry powders for inhalation
WO2014186754A2 (en) 2013-05-16 2014-11-20 Board Of Regents The University Of Texas System Dry solid aluminum adjuvant-containing vaccines and related methods thereof
CN104274426A (zh) * 2013-07-03 2015-01-14 陆克塞纳医药公司 昂丹司琼细粉、昂丹司琼气溶胶组合物及其用途
CN104274427A (zh) * 2013-07-03 2015-01-14 陆克塞纳医药公司 格拉司琼气溶胶组合物及其用途
CN106061482A (zh) 2013-10-08 2016-10-26 拉姆医疗公司 用于治疗淋巴管平滑肌瘤病的雷帕霉素
CN112656780A (zh) 2014-02-20 2021-04-16 奥迪托皮克股份有限公司 用于吸入的干粉制剂
PT3125875T (pt) 2014-04-04 2023-06-29 Ai Therapeutics Inc Uma formulação de rapamicina inalável para tratar estados relacionados com a idade
AU2015296142A1 (en) 2014-07-31 2017-02-23 Otitopic Inc. Dry powder formulations for inhalation
WO2016057712A1 (en) 2014-10-07 2016-04-14 Lam Therapeutics, Inc. An inhalable rapamycin formulation for the treatment of pulmonary hypertension
JP6940416B2 (ja) * 2015-05-01 2021-09-29 ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System 多剤脆性マトリックス組成物
SG10201914118SA (en) 2015-09-01 2020-02-27 First Wave Bio Inc Methods and compositions for treating conditions associated with an abnormal inflammatory responses
EP3440019A1 (en) 2016-04-08 2019-02-13 Remirez, Jose, Antonio Automated dosing system and method with light profiling for wastewater filtration system
EP3485215B1 (en) 2016-07-12 2023-06-07 Alexander Poltorak System and method for maintaining efficiency of a heat sink
WO2018071757A1 (en) 2016-10-14 2018-04-19 Pulmatrix Operating Company, Inc. Antifungal dry powders
WO2019118393A1 (en) 2017-12-11 2019-06-20 Board Of Regents, The University Of Texas System Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration
WO2019204568A1 (en) * 2018-04-20 2019-10-24 Board Of Regents, The University Of Texas System Apparatus and methods for characterizing plume geometry
US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment
WO2021188564A1 (en) 2020-03-16 2021-09-23 First Wave Bio, Inc. Methods of treating covid-19 with a niclosamide compound
CN115515598A (zh) 2020-04-01 2022-12-23 德克萨斯大学系统董事会 氯硝柳胺的药物组合物
WO2021242675A1 (en) 2020-05-26 2021-12-02 Gradalis, Inc. Methods for the treatment of viral respiratory infections
WO2022055817A1 (en) 2020-09-09 2022-03-17 Gradalis, Inc. Composition formulated into inhalable dosage forms for the treatment of lung|tumors
WO2022241105A1 (en) 2021-05-12 2022-11-17 Tff Pharmaceuticals, Inc. Dry powder formulations of tacrolimus for administration by inhalation once daily (qd)
CN118076339A (zh) * 2021-08-30 2024-05-24 德克萨斯大学系统董事会 单克隆抗体干燥粉末
US20230112800A1 (en) 2021-08-31 2023-04-13 Board Of Regents, The University Of Texas System Delayed release niclosamide formulation
WO2024059819A2 (en) 2022-09-15 2024-03-21 Tff Pharmaceuticals, Inc. Compositions of cannabinoids for delivery by inhalation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
JPH1112197A (ja) 1997-06-18 1999-01-19 Cosmo Sogo Kenkyusho:Kk 悪性腫瘍診断剤及び治療剤
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6284282B1 (en) * 1998-04-29 2001-09-04 Genentech, Inc. Method of spray freeze drying proteins for pharmaceutical administration
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6585957B1 (en) 2000-01-25 2003-07-01 Aeropharm Technology Incorporated Medicinal aerosol formulation
PE20020066A1 (es) 2000-06-23 2002-02-23 Norton Healthcare Ltd Deposito de dosis medidas previamente para inhalador de polvo seco accionado por la respiracion
JP2003146523A (ja) 2001-11-15 2003-05-21 Canon Inc 画像形成装置
EP1501483A2 (en) * 2002-04-25 2005-02-02 Nektar Therapeutics UK Ltd Particulate materials
GB0216562D0 (en) * 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
AU2003279070A1 (en) * 2002-09-30 2004-04-23 Acusphere Inc Sustained release porous microparticles for inhalation
KR20050088242A (ko) * 2002-12-31 2005-09-02 넥타르 테라퓨틱스 진균 감염 요법을 위한 에어로졸화가능한 약제학적 제형물
CA2513006A1 (en) 2003-01-15 2004-08-05 Dow Global Technologies Inc. Drug particles obtained by freezing onto a cold surface
CA2538237A1 (en) * 2003-09-10 2005-03-24 Map Pharmaceuticals, Inc. Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
WO2006026502A1 (en) 2004-08-27 2006-03-09 The Dow Chemical Company Enhanced delivery of drug compositions to treat life threatening infections
KR20150064232A (ko) * 2007-05-25 2015-06-10 더 유니버시티 오브 브리티쉬 콜롬비아 치료제의 경구 투여를 위한 제제 및 관련 방법
AU2009214443B2 (en) * 2008-02-13 2013-10-10 Board Of Regents, The University Of Texas System Templated open flocs of anisotropic particles for enhanced pulmonary delivery

Also Published As

Publication number Publication date
US20200069572A1 (en) 2020-03-05
AU2009214443A1 (en) 2009-08-20
US20090208582A1 (en) 2009-08-20
US10092512B2 (en) 2018-10-09
WO2009103035A3 (en) 2009-11-12
US20100221343A1 (en) 2010-09-02
EP2252275A4 (en) 2013-11-06
US20190117557A1 (en) 2019-04-25
EP2252275B1 (en) 2017-11-29
DK2252275T3 (en) 2018-03-05
US20210007971A1 (en) 2021-01-14
CA2723314A1 (en) 2009-08-20
CA2723314C (en) 2017-01-10
EP2252275A2 (en) 2010-11-24
US20220354778A1 (en) 2022-11-10
AU2009214443B2 (en) 2013-10-10
US11364197B2 (en) 2022-06-21
US10434062B2 (en) 2019-10-08
WO2009103035A2 (en) 2009-08-20
US10660850B2 (en) 2020-05-26

Similar Documents

Publication Publication Date Title
BR112016019572A2 (ko)
BRPI0909040A2 (ko)
BRPI0917573A2 (ko)
BRPI0908549B8 (ko)
BRPI0918697A2 (ko)
BRPI0917525A2 (ko)
BRPI0919470A2 (ko)
BRPI0907698A2 (ko)
BRPI0917618A8 (ko)
BRPI0912727A2 (ko)
NO2252275T3 (ko)
BRPI0908285A2 (ko)
BRPI0910485A2 (ko)
BRPI0914750A2 (ko)
BRPI0908120A2 (ko)
BRPI0912462A2 (ko)
BRPI0915616A2 (ko)
BRPI0904541A8 (ko)
BRPI0916284A2 (ko)
BRPI0909508A2 (ko)
BRPI0913605A2 (ko)
BRPI0911617A2 (ko)
BRPI0914852A2 (ko)
BRPI0910572A2 (ko)
BRPI0914820A2 (ko)